The firm is an ophthalmic medical device company headquartered in Beijing with offices in Hong Kong and Europe. The firm is actively seeking external innovations in the ophthalmic device space and is looking for early-stage companies that have strategic alignment with the firm. The firm works with early-stage startups using a variety of structures, including equity investments, in-licensing, acquisition, joint-venture and distribution. The firm can help companies grow in China market, where they can leverage their resources in many ways, like supporting CFDA approval, engineering, manufacturing, distribution and after-sale services. The firm is a multi-stage investor and is interested in new technologies worldwide.
The company invests in ophthalmic medical devices that have proof of concept done and a prototype ready.
The company does not have specific requirements for the company’s management team. The firm will consider taking board seats on a case-by-case basis.
If you are interested in more information about this investor and other investors tracked by LSN, please email LHI@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply